Observational study finds rising antibiotic resistance among children in high-income countries — Evidence Review
Published in JAMA Pediatrics, by researchers from Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, University of Melbourne
Researched by
— the AI search engine for science
Table of Contents
Antibiotic resistance in childhood infections is rising globally, with a new study projecting further increases—especially for critical antibiotics—by 2035. Related studies generally confirm these trends, highlighting the urgent need for improved antibiotic stewardship and surveillance in pediatric populations, as detailed by the study published in JAMA Pediatrics.
- Multiple recent reviews and meta-analyses indicate that antibiotic resistance in children is increasing worldwide, with particularly high rates in low- and middle-income countries; these findings are consistent with the new study’s regional trends and predicted future burden 1 2 4 5 7.
- Overuse and misuse of antibiotics in both clinical and community settings, as well as easy access to antibiotics without prescription, are repeatedly identified as key drivers of resistance in children, supporting the new study's call for urgent interventions 1 3 9.
- The new study’s focus on "Watch" and "Reserve" antibiotics aligns with growing concern in the literature about emerging multidrug-resistant organisms and the potential for a post-antibiotic era, especially with pathogens like Acinetobacter baumannii and Klebsiella spp. 2 6 10.
Study Overview and Key Findings
Antibiotic resistance is often discussed in adult populations, but pediatric-specific data has been limited and fragmented. This new global analysis addresses a crucial knowledge gap by focusing exclusively on children and adolescents, using a large, diverse dataset covering 82 countries over nearly two decades. By modeling both historical trends and future projections, the study provides a rare, comprehensive view of antibiotic resistance in children—a population with fewer treatment options and distinct clinical challenges.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, University of Melbourne |
| Journal Name | JAMA Pediatrics |
| Authors | Hu, Y.J., Qiu, H., Harwell, J.I., Bryant, P. A. |
| Population | Children and teens ages 0 to 18 |
| Sample Size | over 106,000 bacterial samples |
| Methods | Observational Study |
| Outcome | Antibiotic resistance rates among children |
| Results | Resistance to Watch antibiotics rose from 14% to 24% in high-income countries. |
Key Findings:
- The study analyzed over 106,000 bacterial samples from children aged 0–18 across 82 countries between 2004 and 2022.
- It found antibiotic resistance increasing globally in pediatric infections, with steep rises projected for critical antibiotics (especially "Watch" and "Reserve" categories) by 2035.
- Resistance to "Watch" antibiotics—including key drugs used for resistant infections—rose from 14% to 24% in high-income countries and from 16% to 48% in low-income settings over the study period.
- The highest resistance levels and steepest increases were observed in low-resource countries, but high-income regions are also affected.
- Resistance to "Reserve" (last-line) antibiotics also increased, though less sharply than "Watch" antibiotics.
- The study cautions that these projections assume current trends continue and emphasizes that coordinated action could change the trajectory.
Literature Review: Related Studies
To place these findings in context, we searched the Consensus database, which includes over 200 million research papers. The following search queries were used:
- antibiotic resistance children high-income countries
- global trends antibiotic resistance pediatric
- Watch antibiotics resistance prevalence increase
| Topic | Key Findings |
|---|---|
| What are the global and regional trends in pediatric antibiotic resistance? | - Resistance in children is rising worldwide, with especially high rates and faster increases in low- and middle-income countries 1 2 4 5 7 10. - Multidrug-resistant organisms (including MRSA, ESBL-producing Enterobacteriaceae, carbapenem-resistant strains) are increasingly reported in children 2 6 7 10. |
| How do patterns of antibiotic use and access impact resistance in children? | - Overuse, misuse, and self-medication with antibiotics are strongly linked to increased resistance, particularly where antibiotics are easily available without prescription 1 3 4 9. - Previous antibiotic exposure in primary care significantly raises the risk of resistant infections in children 1 3. |
| What are the clinical implications and emerging threats in pediatric antibiotic resistance? | - Rising resistance to key antibiotics threatens the effectiveness of first-line and last-resort therapies, with some reviews warning of a "post-antibiotic era" for pathogens like Acinetobacter baumannii 2 5 6 10. - Resistance is associated with increased morbidity, mortality, and limited treatment options in children 2 5 6. |
| What surveillance and stewardship strategies are recommended to address pediatric resistance? | - Improved pediatric-specific surveillance and data granularity are needed to guide stewardship and policy 2 5 7. - National and regional monitoring programs, as well as stricter regulations on antibiotic use and access, are repeatedly recommended 5 7 9. |
What are the global and regional trends in pediatric antibiotic resistance?
The related studies show broad agreement with the new study's finding of rising antibiotic resistance in children, with the burden especially high and increasing in lower-income regions. Both the current study and recent reviews highlight accelerating resistance in critical pathogens (such as Acinetobacter baumannii and Klebsiella), and note that multidrug resistance is an increasing concern for pediatric populations worldwide 1 2 4 5 7 10.
- Resistance levels are significantly higher in low- and middle-income countries, but high-income countries are seeing faster relative increases for certain pathogens 1 4 10.
- Multidrug-resistant organisms (MDROs), including MRSA and carbapenem-resistant strains, are now commonly reported in pediatric settings 2 6 7 10.
- The new study's projected trends to 2035 are in line with past warnings that a "post-antibiotic era" is possible if trends continue 2 10.
- Ongoing, large-scale surveillance (like the ISPED program in China) has revealed similar patterns of high and rising resistance, as well as regional variations 7.
How do patterns of antibiotic use and access impact resistance in children?
There is strong evidence that inappropriate antibiotic use—including overprescribing, self-medication, and easy over-the-counter access—drives resistance in pediatric populations. This is especially pronounced in regions lacking strict regulatory controls, reinforcing the new study's observation that resistance is rising fastest where access is least controlled 1 3 4 9.
- Prior antibiotic use in children is a key risk factor for resistant infections, with effects lasting months 1.
- Self-medication and non-prescription antibiotic sales are prevalent in Asia, Africa, and South America, contributing to higher resistance rates 3 9.
- Inadequate sanitation, limited healthcare access, and unregulated sales compound the problem in lower-income settings 4 9.
- Educational and regulatory interventions targeting prescribing behaviors and public awareness have been recommended 3 9.
What are the clinical implications and emerging threats in pediatric antibiotic resistance?
Rising resistance is increasingly limiting treatment options for children, with several studies warning of emerging threats from multidrug-resistant and last-resort-drug-resistant bacteria. The new study’s findings on “Watch” and “Reserve” antibiotics are echoed in the literature, which highlights the clinical risks of resistance in key pathogens like ESBL-producing Enterobacteriaceae and Acinetobacter baumannii 2 5 6 10.
- Resistance to first-line (Access) and last-resort (Reserve) antibiotics is rising, with treatment failures and higher mortality risks in children 2 5 6.
- The prevalence of resistance in Helicobacter pylori, E. coli, and other key pathogens is increasing globally, with urgent calls for stewardship 1 5.
- Transmissible resistance and horizontal gene transfer are important mechanisms spreading resistance among pediatric pathogens 6.
- Without effective interventions, projections suggest routine childhood infections could become untreatable 2 10.
What surveillance and stewardship strategies are recommended to address pediatric resistance?
Literature emphasizes that more granular, pediatric-focused surveillance is essential to inform stewardship and policy. The new study's approach—analyzing a large, diverse pediatric dataset—is in line with these recommendations, but highlights the ongoing need for representative sampling and harmonized monitoring protocols 2 5 7.
- National and regional surveillance networks are needed to track resistance trends and inform guidelines 5 7.
- Pediatric-specific data is often obscured by aggregated adult data, leading to under-recognition of child-specific resistance trends 2 7.
- Antimicrobial stewardship programs, including regulation of sales and improved prescribing practices, are recommended as key strategies 5 9.
- Improved laboratory capacity, data sharing, and research on pediatric pharmacokinetics are identified as priorities 2 5 7.
Future Research Questions
While this study provides new insights, further research is needed to address important gaps—particularly regarding the drivers of resistance, effectiveness of interventions, and real-world outcomes in diverse pediatric populations.
| Research Question | Relevance |
|---|---|
| How effective are antibiotic stewardship interventions in reducing resistance rates in children? | Understanding which stewardship strategies are most effective in pediatric settings is critical for designing policies that can alter current resistance trajectories 2 5 7 9. |
| What are the long-term clinical outcomes of antibiotic-resistant infections in children? | There is limited data on the long-term health, developmental, and mortality impacts of resistant infections in pediatric populations, which is important for risk assessment and resource allocation 2 5 6. |
| How do socioeconomic factors and healthcare access affect antibiotic resistance in children globally? | Identifying and quantifying the impact of factors such as income, education, and health system capacity can inform targeted interventions and policy prioritization 3 4 9. |
| How does early-life antibiotic exposure impact the child gut microbiome and resistome? | Early antibiotic use can alter the microbiome and increase resistance gene abundance, but more research is needed to understand the mechanisms and long-term health consequences 4. |
| What are the most cost-effective surveillance strategies for tracking pediatric antibiotic resistance in low-resource settings? | Surveillance is critical but often limited by resources; identifying scalable, affordable monitoring approaches is essential for global health security, especially in high-burden regions 5 7 9. |
This evidence-based overview highlights the growing challenge of antibiotic resistance in children, the factors driving this trend, and the urgent need for coordinated research and policy action globally.